{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T05:26:05Z","timestamp":1783229165159,"version":"3.54.6"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T00:00:00Z","timestamp":1363392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00259-013-2372-4","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T21:38:19Z","timestamp":1363383499000},"page":"1014-1024","source":"Crossref","is-referenced-by-count":25,"title":["Detection of underlying malignancy in patients with paraneoplastic neurological syndromes: comparison of 18F-FDG PET\/CT and contrast-enhanced CT"],"prefix":"10.1007","volume":"40","author":[{"given":"N.","family":"Schramm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rominger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. N.","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schmid-Tannwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. G.","family":"Meinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,16]]},"reference":[{"key":"2372_CR1","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2000;284:3043\u20135.","DOI":"10.1001\/jama.284.23.3043"},{"issue":"Suppl 1","key":"2372_CR2","first-page":"56S","volume":"45","author":"G Antoch","year":"2004","unstructured":"Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET\/CT. J Nucl Med. 2004;45 Suppl 1:56S\u201365S.","journal-title":"J Nucl Med"},{"key":"2372_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1531-8249(200007)48:1<105::AID-ANA16>3.0.CO;2-G","volume":"48","author":"JC Antoine","year":"2000","unstructured":"Antoine JC, Cinotti L, Tilikete C, Bouhour F, Camdessanch\u00e9 JP, Confavreux C, et al. [18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies. Ann Neurol. 2000;48:105\u20138.","journal-title":"Ann Neurol"},{"key":"2372_CR4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00330-009-1606-0","volume":"20","author":"P Bannas","year":"2010","unstructured":"Bannas P, Weber C, Derlin T, Lambert J, Leypoldt F, Adam G, et al. 18F-FDG-PET\/CT in the diagnosis of paraneoplastic neurological syndromes: a retrospective analysis. Eur Radiol. 2010;20:923\u201330.","journal-title":"Eur Radiol"},{"key":"2372_CR5","first-page":"1200","volume":"44","author":"R Bar-Shalom","year":"2003","unstructured":"Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET\/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200\u20139.","journal-title":"J Nucl Med"},{"key":"2372_CR6","doi-asserted-by":"crossref","first-page":"17N","DOI":"10.2967\/jnumed.108.050401","volume":"49","author":"S Basu","year":"2008","unstructured":"Basu S, Alavi A. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. J Nucl Med. 2008;49:17N\u201321N 37N.","journal-title":"J Nucl Med"},{"key":"2372_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1470-2045(00)00257-6","volume":"2","author":"JB Bomanji","year":"2001","unstructured":"Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol. 2001;2:157\u2013164.","journal-title":"Lancet Oncol"},{"key":"2372_CR8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/000348941112000907","volume":"120","author":"EC Cashman","year":"2011","unstructured":"Cashman EC, Macmahon PJ, Shelly MJ, Kavanagh EC. Role of positron emission tomography-computed tomography in head and neck cancer. Ann Otol Rhinol Laryngol. 2011;120:593\u2013602.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2372_CR9","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2214\/ajr.170.6.9609164","volume":"170","author":"C Chartrand-Lefebvre","year":"1998","unstructured":"Chartrand-Lefebvre C, Howarth N, Grenier P, Keime F, Orcel B, Beigelman C. Association of small cell lung cancer and the anti-Hu paraneoplastic syndrome: radiographic and CT findings AJR Am J Roentgenol 1998;170:1513\u2013157.","journal-title":"AJR Am J Roentgenol"},{"key":"2372_CR10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008;7:327\u201340.","journal-title":"Lancet Neurol"},{"key":"2372_CR11","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"RB Darnell","year":"2003","unstructured":"Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349:1543\u201354.","journal-title":"N Engl J Med"},{"key":"2372_CR12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00415-005-0635-0","volume":"252","author":"M Frings","year":"2005","unstructured":"Frings M, Antoch G, Knorn P, Freudenberg L, Bier U, Timmann D, et al. Strategies in detection of the primary tumour in anti-Yo associated paraneoplastic cerebellar degeneration. J Neurol. 2005;252:197\u2013201.","journal-title":"J Neurol"},{"key":"2372_CR13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2372_CR14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","volume":"124","author":"F Graus","year":"2001","unstructured":"Graus F, Keime-Guibert F, Rene R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138\u201348.","journal-title":"Brain"},{"key":"2372_CR15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-0404.2008.01089.x","volume":"119","author":"M Hadjivassiliou","year":"2009","unstructured":"Hadjivassiliou M, Alder SJ, Van Beek EJ, Hanney MB, Lorenz E, Rao DG, et al. PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit. Acta Neurol Scand. 2009;119:186\u201393.","journal-title":"Acta Neurol Scand"},{"key":"2372_CR16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","volume":"68","author":"F Keime-Guibert","year":"2000","unstructured":"Keime-Guibert F, Graus F, Fleury A, Ren\u00e9 R, Honnorat J, Broet P, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000;68:479\u201382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2372_CR17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12149-009-0283-z","volume":"23","author":"A Kumar","year":"2009","unstructured":"Kumar A, Regmi SK, Dutta R, Kumar R, Gupta SD, Das P, et al. Characterization of thymic masses using (18)F-FDG PET-CT. Ann Nucl Med. 2009;23:569\u201377.","journal-title":"Ann Nucl Med"},{"key":"2372_CR18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1212\/01.WNL.0000129983.06983.4E","volume":"63","author":"R Linke","year":"2004","unstructured":"Linke R, Schroeder M, Helmberger T, Voltz R. Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology. 2004;63:282\u20136.","journal-title":"Neurology"},{"key":"2372_CR19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejrad.2007.02.040","volume":"62","author":"J Liu","year":"2007","unstructured":"Liu J, Xu Y, Wang J. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma. Eur J Radiol. 2007;62:328\u201334.","journal-title":"Eur J Radiol"},{"key":"2372_CR20","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/BF01791148","volume":"22","author":"RS Liu","year":"1995","unstructured":"Liu RS, Yeh SH, Huang MH, Wang LS, Chu LS, Chang CP, et al. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report. Eur J Nucl Med. 1995;22:1402\u20137.","journal-title":"Eur J Nucl Med"},{"key":"2372_CR21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/RLU.0b013e3182393390","volume":"37","author":"A Matsuhisa","year":"2012","unstructured":"Matsuhisa A, Toriihara A, Kubota K, Makino T, Mizusawa H, Shibuya H, et al. Utility of F-18 FDG PET\/CT in screening for paraneoplastic neurological syndromes. Clin Nucl Med. 2012;37:39\u201343.","journal-title":"Clin Nucl Med"},{"key":"2372_CR22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0025-6196(11)60768-4","volume":"83","author":"RR Patel","year":"2008","unstructured":"Patel RR, Subramaniam RM, Mandrekar JN, Hammack JE, Lowe VJ, Jett JR, et al. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc 2008;83:917\u201322.","journal-title":"Mayo Clin Proc"},{"key":"2372_CR23","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/brain\/124.11.2223","volume":"124","author":"JH Rees","year":"2001","unstructured":"Rees JH, Hain SF, Johnson MR, Hughes RA, Costa DC, Ell PJ, et al. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain. 2001;124:2223\u201331.","journal-title":"Brain"},{"key":"2372_CR24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/WNL.55.5.713","volume":"55","author":"I Rojas","year":"2000","unstructured":"Rojas I, Graus F, Keime-Guibert F, Re\u00f1\u00e9 R, Delattre JY, Ram\u00f3n JM, et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology. 2000;55:713\u20135.","journal-title":"Neurology"},{"key":"2372_CR25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1634\/theoncologist.2010-0001","volume":"15","author":"MR Rosenfeld","year":"2010","unstructured":"Rosenfeld MR, Dalmau J. Update on paraneoplastic neurologic disorders. Oncologist. 2010;15:603\u201317.","journal-title":"Oncologist"},{"key":"2372_CR26","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/1097-4598(200012)23:12<1800::AID-MUS3>3.0.CO;2-X","volume":"23","author":"SA Rudnicki","year":"2000","unstructured":"Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the spinal cord, nerve, and muscle. Muscle Nerve. 2000;23:1800\u201318.","journal-title":"Muscle Nerve"},{"key":"2372_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","volume":"18","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Soffietti R, Dalmau J, Gilhus NE, Giometto B, Graus F, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011;18:19\u2013e13.","journal-title":"Eur J Neurol"},{"key":"2372_CR28","doi-asserted-by":"crossref","unstructured":"Titulaer MJ, Wirtz PW, Willems LN, van Kralingen KW, Smitt PA, Verschuuren JJ, et al. Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome. J Clin Oncol. 2008;26:4276\u201381.","DOI":"10.1200\/JCO.2008.17.5133"},{"key":"2372_CR29","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1097\/RLU.0b013e31821c9a9a","volume":"36","author":"T Tsujikawa","year":"2011","unstructured":"Tsujikawa T, Tsuchida T, Yoshida Y, Kurokawa T, Kiyono Y, Okazawa H, et al. Role of PET\/CT in gynecological tumors based on the revised FIGO staging classification. Clin Nucl Med. 2011;36:e114\u20138.","journal-title":"Clin Nucl Med"},{"key":"2372_CR30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","volume":"13","author":"CA Vedeler","year":"2006","unstructured":"Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, Hart IK, et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006;13:682\u201390.","journal-title":"Eur J Neurol"},{"key":"2372_CR31","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1474-4422(02)00135-7","volume":"1","author":"R Voltz","year":"2002","unstructured":"Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol. 2002;1:294\u2013305.","journal-title":"Lancet Neurol"},{"key":"2372_CR32","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/brain\/awh247","volume":"127","author":"S Younes-Mhenni","year":"2004","unstructured":"Younes-Mhenni S, Janier MF, Cinotti L, Antoine JC, Tronc F, Cottin V, et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain. 2004;127:2331\u20138.","journal-title":"Brain"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2372-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-013-2372-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2372-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:05:26Z","timestamp":1558713926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-013-2372-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,16]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2372"],"URL":"https:\/\/doi.org\/10.1007\/s00259-013-2372-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,16]]}}}